Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

被引：0
|
作者：
Mushtaq, Adeela
Latif, Azka
Kapoor, Vikas
Warraich, Faiza Hassan
Warraich, Sami Ullah
Iftikhar, Ahmad
Tenneti, Pavan
Zafar, Raahem Nayab
Russ, Atlantis Dawn
Abraham, Ivo
McBride, Ali
Anwer, Faiz
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5413
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma
    Neupane, Karun
    Ahmed, Zahoor
    Ashraf, Rabia
    Khan, Amna
    Shahzad, Moazzam
    Farooqui, Arafat Ali
    Faisal, Muhammad Salman
    Abdullah, Syed Maaz
    Kashyap, Richi
    Ehsan, Hamid
    Anwer, Faiz
    BLOOD, 2020, 136
  • [42] Efficacy and Safety Profile of Proteasome Inhibitor Based Drug Regimens for Treatment of Newly Diagnosed AL Amyloidosis: A Systematic Review
    Javed, Saad
    Syed, Tariq Iqtidar Sadiq
    Fatima, Hejab
    Inam, Syed Hashim Ali
    Rehan, Tayyab
    Abdullah, Syed Maaz
    Najmuddin, Mohammed Musa
    Haider, Mobeen Zaka
    Neupane, Karun
    Sana, Muhammad Khawar
    Dar, Abdul Jabbar
    Jaan, Ali
    Mirza, Muhammad Ali
    Anwer, Faiz
    BLOOD, 2020, 136
  • [43] A Systematic Review on Efficacy and Safety of Bortezomib Based Regimens for Treatment of Waldensterom Macroglobulinemia
    Dar, Abdul Jabbar
    Khurshid, Qasim
    Ahmad, Muhaddis Ejaz
    Mirza, Muhammad Ali
    Khalid, Farhan
    Jaan, Ali
    Abdullah, Syed Maaz
    Farooqi, Muhammad Saad
    Khan, Atif Irfan
    Kashyap, Richi
    Khan, Anam
    Javed, Saad
    Qamar, Fazeel
    Anwer, Faiz
    BLOOD, 2020, 136
  • [44] Efficacy Of Bortezomib-Based Regimens With Or Without An Immunomodulatory Agent In Older Adults With Multiple Myeloma: A Systematic Review and Meta-Analysis
    Atkins, Jordan
    Fowler, Susan A.
    Tuuli, Methodius
    James, Aimee S.
    Wildes, Tanya M.
    BLOOD, 2013, 122 (21)
  • [45] Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis
    Xu, Linchun
    Lin, Shaoze
    Xing, Xueyang
    Su, Yongzhong
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [46] EFFICACY OF DARATUMUMAB-BASED REGIMENS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA - A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
    Dimopoulos, M. A.
    Weisel, K.
    Kaufman, J.
    Sonneveld, P.
    Rizzo, M.
    Xu, Y.
    Fahrbach, K.
    Gaudig, M.
    Slavcev, M.
    Dearden, L.
    Lam, A.
    HAEMATOLOGICA, 2017, 102 : 525 - 526
  • [47] Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis
    Wang, Yin
    Li, Yanqing
    Chai, Ye
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
  • [48] Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma
    Reece, Donna
    Song, Kevin
    LeBlanc, Richard
    Mezzi, Khalid
    Olujohungbe, Ade
    White, Darrell
    Zaman, Faraz
    Belch, Andrew
    ONCOLOGIST, 2013, 18 (05): : 611 - 618
  • [49] EFFICACY AND SAFETY OF CARFILZOMIB IN PATIENTS WITH MULTIPLE RECALLED / REFRACTORY MYELOMA
    Pimentel, Feliciano Ana
    Amarilla, Lanzas Irene
    Gracia, Piquer Raquel
    Valera, Martinez Isabel
    Rivas, Esteban Irene
    Ortiz, Lopez Alicia
    Angos, Vazquez Sonia
    Gemperle, Ortiz Natalia
    Dourdil, Sahun Victoria
    Bonafonte, Arruga Elena
    Martinez, Lazaro Beatriz
    Palomera, Bernal Luis
    HAEMATOLOGICA, 2020, 105 : 368 - 369
  • [50] Carfilzomib and Pomalidomide: Recent Advances in the Treatment of Multiple Myeloma
    Highsmith, Kaitlin N.
    Chen, Sheree E.
    Horowitz, Sandy
    PHARMACOTHERAPY, 2014, 34 (09): : 927 - 940
12345